Vaccination for the prevention and treatment of Alzheimer's disease

Drugs of Today

Volumn 36, Issue 9, 2000, Pages 655-663

  Solomon, B ^a   Frenkel, D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATING BETA AMYLOID PEPTIDE ANTIBODY; AMYLOID BETA PROTEIN; ANTIGEN; AUTOANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID NEUROPATHY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; GUINEA PIG; IMMUNOPROPHYLAXIS; NEUROPATHOLOGY; NONHUMAN; PHAGE DISPLAY; PROTEIN AGGREGATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; REVIEW; SEQUENCE HOMOLOGY; SOLUBILIZATION; TRANSGENIC MOUSE;

EID: 0033783730     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2000.36.9.593782     Document Type: Review

References (44)

1. Alzheimer disease and the prion disorders amyloid β-protein and prion protein amyloidoses
2. Mutations and off-pathway aggregation of proteins
3. Amyloid deposition as the central event in the aetiology of Alzheimer's disease
4. Amyloid β-protein and the genetics of Alzheimer's disease
5. Amyloid, the presenilins and Alzheimer's disease
6. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
7. Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau
8. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
9. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
10. β-Amyloid and treatment opportunities for Alzheimer's disease
11. Amyloid β-peptide is produced by cultured cells during normal metabolism
12. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
13. Brain amyloid: A physicochemical perspective
14. Is amyloid deposition in Alzheimer's disease preceded by an environment induced double conformational transition?
15. The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation
16. Solution structures of β-peptide and its constituent fragments: Relation to amyloid deposition
17. pH-Dependent conformations of the amyloid β(1-28) peptide fragment explored using molecular dynamics
18. Synthetic peptide homologous to β-protein from Alzheimer disease forms amyloid-like fibrils in vitro
19. Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro
20. The α-yltic protease pro-region does not require a physical linkage to activate the protese domain in vivo
21. Thermostabilization of carboxypeptidase A by interaction with its monoclonal antibodies
22. Effect of monoclonal antibodies in preventing carboxypeptidase A aggregation
23. Partly native epitopes are already present on early intermediates in the folding of tryptophan synthase
24. Chaperone-like effect of monoclonal antibodies on refolding of heat-denatured carboxypeptidase A
25. Disaggregation of Alzheimer β-amyloid by site-directed mAb
26. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer's β-amyloid peptide
27. Immunization with amyloid-β attenuates Alzheimer's disease-like pathology in the PDAPP mouse
28. Searching for peptide ligands with an epitope library
29. Discovering peptide ligands using epitope libraries
30. Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library
31. Phage display: All dressed up and ready to role
32. N-Terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregating antibodies
33. Intracellular antibodies: Development and therapeutic potential
34. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases
35. Making antibody by phage display technology
36. Antibody phage display technology and its applications
37. Modulation of Alzheimer's β-amyloid neurotoxicity by site-directed single-chain antibody
38. Multiple display of foreign peptides on a filamentous bacteriophage
39. Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage
40. Recognition by human sera and immunogenicity of HbsAg mimotopes selected from an M13 phage display library
41. Derivation of vaccines from mimotopes: Immunological properties of human B virus surface antigen mimotopes displayed on filamentous phage
42. Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration
43. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
44. An improved MTT assay